Potentiation of the inhibition of rat liver monoamine oxidase-a by clorgyline after pretreatment with SKF 525A.
Pretreatment of rat liver homogenates with 1.5 x 10(-4) M SKF 525A is without effect on the activity of monoamine oxidase-A, but results in a decrease in the concentration of clorgyline required for the inhibition of this enzyme form. Such a result is consistent with the hypothesis that rat liver homogenates contain an SKF 525A-sensitive clorgyline-metabolising system.